The chances of a patient with melanoma developing in transit disease are doubled by undergoing sentinel lymph node biopsy (SLNB)
- PMID: 15698741
- DOI: 10.1016/j.ejso.2004.10.009
The chances of a patient with melanoma developing in transit disease are doubled by undergoing sentinel lymph node biopsy (SLNB)
Comment on
-
Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma.Eur J Surg Oncol. 2004 Aug;30(6):686-91. doi: 10.1016/j.ejso.2004.04.004. Eur J Surg Oncol. 2004. PMID: 15256245 Review.
Similar articles
-
Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma.Eur J Surg Oncol. 2005 Mar;31(2):211-2. doi: 10.1016/j.ejso.2004.09.015. Eur J Surg Oncol. 2005. PMID: 15698742 No abstract available.
-
[Sentinel lymph node biopsy and incidence of recurrence].Hautarzt. 2006 Mar;57(3):182. Hautarzt. 2006. PMID: 17429861 German. No abstract available.
-
Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma.Eur J Surg Oncol. 2004 Aug;30(6):686-91. doi: 10.1016/j.ejso.2004.04.004. Eur J Surg Oncol. 2004. PMID: 15256245 Review.
-
Re: Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma, Thomas and Clark.Eur J Surg Oncol. 2005 Apr;31(3):323-4. doi: 10.1016/j.ejso.2004.11.010. Eur J Surg Oncol. 2005. PMID: 15780572 No abstract available.
-
Sentinel node mapping for melanoma: results of trials and current applications.Surg Oncol Clin N Am. 2007 Jan;16(1):35-54. doi: 10.1016/j.soc.2006.10.013. Surg Oncol Clin N Am. 2007. PMID: 17336235 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical